Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 9, 2009, Pages 4029-4032

  Pemp, Berthold ^a   Garhofer, Gerhard ^a   Weigert, Günther ^a   Karl, Katharina ^a   Resch, Hemma ^a   Wolzt, Michael ^a   Schmetterer, Leopold ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; NITRIC OXIDE; VASODILATOR AGENT;

ADULT; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUMINANCE; MALE; PHOTOSTIMULATION; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD VESSEL; RETINA VEIN; VASODILATATION; VEIN DIAMETER; BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INTRAOCULAR PRESSURE; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; VISUAL ACUITY;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTRAOCULAR PRESSURE; MALE; NITRIC OXIDE; NITROGLYCERIN; PHOTIC STIMULATION; RETINAL VESSELS; VASODILATION; VASODILATOR AGENTS; VISUAL ACUITY;

EID: 70349249516     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3260     Document Type: Article

References (25)

1. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol. 2004;88(7):887-891.
2. Mandecka A, Dawczynski J, Blum M, et al. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care. 2007;30(12):3048-3052.
3. Dorner GT, Garhofer G, Kiss B, et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol. 2003; 285(2):H631-H636.
4. Rassam SM, Patel V, Kohner EM. The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy. Exp Physiol. 1995;80(1):53-68.
5. Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T. The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1255-1261.
6. Schmetterer L, Findl O, Fasching P, et al. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes. 1997;46(4):653-658.
7. Santilli F, Cipollone F, Mezzetti A, Chiarelli F. The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res. 2004;36(5):319-335.
8. Arend O, Wolf S, Remky A, et al. Perifoveal microcirculation with non-insulin-dependent diabetes mellitus. Graefes Arch Clin Exp Ophthalmol. 1994;232(4):225-231.
9. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16(3):242-260.
10. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98(5 suppl): 823-833.
11. Polak K, Dorner G, Kiss B, et al. Evaluation of the Zeiss retinal vessel analyser. Br J Ophthalmol. 2000;84(11):1285-1290.
12. Klein BE, Klein R, McBride PE, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med. 2004;164(17):1917-1924.
13. Michelson G, Wärntges S, Harazny J, Oehmer S, Delles C, Schmieder RE. Effect of NOS inhibition on retinal arterial and capillary circulation in early arterial hypertension. Retina. 2006; 26(4):437-444.
14. Pemp B, Schmetterer L. Ocular blood flow in diabetes and agerelated macular degeneration. Can J Ophthalmol. 2008;43(3):295-301.
15. Guan K, Hudson C, Wong T, et al. Retinal hemodynamics in early diabetic macular edema. Diabetes. 2006;55(3):813-818.
16. Grunwald JE, Riva CE, Petrig BL, Sinclair SH, Brucker AJ. Effect of pure O2-breathing on retinal blood flow in normals and in patients with background diabetic retinopathy. Curr Eye Res. 1984;3(1): 239-241.
17. Grunwald JE, Riva CE, Baine J, Brucker AJ. Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci. 1992;33(2):356-363.
18. Gilmore ED, Hudson C, Nrusimhadevara RK, et al. Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy. Invest Ophthalmol Vis Sci. 2007;48(4):1744-1750.
19. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90(6):2548-2554.
20. Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, Lechi A. Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care. 1995;18(7):975-982.
21. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(8):771-776.
22. Huvers FC, Schaper NC, Houben AJ, et al. Impaired arterial but not venous responsiveness to nitroglycerin in non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1997;27(5):360-365.
23. Dorner GT, Garhöfer G, Huemer KH, Riva CE, Wolzt M, Schmetterer L. Hyperglycemia affects flicker-induced vasodilation in the retina of healthy subjects. Vision Res. 2003;43(13):1495-1500.
24. Gilmore ED, Hudson C, Nrusimhadevara RK, et al. Retinal arteriolar hemodynamic response to a combined isocapnic hyperoxia and glucose provocation in early sight-threatening diabetic retinopathy. Invest Ophthalmol Vis Sci. 2008;49(2):699-705.
25. Feke GT, Buzney SM, Ogasawara H, et al. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci. 1994; 35(7):2968-2975.